Follow
Marta Luksza
Marta Luksza
Verified email at mssm.edu
Title
Cited by
Cited by
Year
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
X Mei, HC Lee, K Diao, M Huang, B Lin, C Liu, Z Xie, Y Ma, PM Robson, ...
Nature medicine 26 (8), 1224-1228, 2020
10212020
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ...
Nature 551 (7681), 512-516, 2017
9822017
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
M Łuksza, N Riaz, V Makarov, VP Balachandran, MD Hellmann, ...
Nature 551 (7681), 517-520, 2017
5912017
A predictive fitness model for influenza
M Łuksza, M Lässig
Nature 507 (7490), 57-61, 2014
4322014
Introductions and early spread of SARS-CoV-2 in the New York City area
AS Gonzalez-Reiche, MM Hernandez, MJ Sullivan, B Ciferri, ...
Science 369 (6501), 297-301, 2020
4092020
COVID-19 in patients with lung cancer
J Luo, H Rizvi, IR Preeshagul, JV Egger, D Hoyos, C Bandlamudi, ...
Annals of Oncology 31 (10), 1386-1396, 2020
2912020
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
LA Rojas, Z Sethna, KC Soares, C Olcese, N Pang, E Patterson, J Lihm, ...
Nature 618 (7963), 144-150, 2023
2562023
Predictive modeling of influenza shows the promise of applied evolutionary biology
DH Morris, KM Gostic, S Pompei, T Bedford, M Łuksza, RA Neher, ...
Trends in microbiology 26 (2), 102-118, 2018
1162018
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
M Łuksza, ZM Sethna, LA Rojas, J Lihm, B Bravi, Y Elhanati, K Soares, ...
Nature 606 (7913), 389-395, 2022
962022
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
K Vanshylla, C Fan, M Wunsch, N Poopalasingam, M Meijers, C Kreer, ...
Cell host & microbe 30 (1), 69-82. e10, 2022
452022
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
F Maura, EH Rustad, V Yellapantula, M Łuksza, D Hoyos, KH Maclachlan, ...
Leukemia 34 (5), 1476-1480, 2020
422020
Garvan Institute of Medical Research; Prince of Wales Hospital; Royal North Shore Hospital; University of Glasgow; St Vincent’s Hospital; QIMR Berghofer Medical Research …
VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ...
Institute for Molecular Bioscience, 512-516, 2017
412017
Hybrid gene origination creates human-virus chimeric proteins during infection
JSY Ho, M Angel, Y Ma, E Sloan, G Wang, C Martinez-Romero, ...
Cell 181 (7), 1502-1517. e23, 2020
392020
Fierce selection and interference in B-cell repertoire response to chronic HIV-1
A Nourmohammad, J Otwinowski, M Łuksza, T Mora, AM Walczak
Molecular biology and evolution 36 (10), 2184-2194, 2019
392019
Fundamental immune–oncogenicity trade-offs define driver mutation fitness
D Hoyos, R Zappasodi, I Schulze, Z Sethna, KC de Andrade, DF Bajorin, ...
Nature 606 (7912), 172-179, 2022
292022
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
A Ravi, MD Hellmann, MB Arniella, M Holton, SS Freeman, V Naranbhai, ...
Nature genetics 55 (5), 807-819, 2023
272023
Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave
MM Hernandez, AS Gonzalez-Reiche, H Alshammary, S Fabre, Z Khan, ...
Nature Communications 12 (1), 3463, 2021
162021
Artificial intelligence for rapid identification of the coronavirus disease 2019 (COVID-19)
X Mei, HC Lee, M Huang, B Lin, C Liu, Z Xie, Y Ma, PM Robson, M Chung, ...
MedRxiv, 2020.04. 12.20062661, 2020
102020
Epidemiological and evolutionary analysis of the 2014 Ebola virus outbreak
M Łuksza, T Bedford, M Lässig
arXiv preprint arXiv:1411.1722, 2014
102014
Population immunity predicts evolutionary trajectories of SARS-CoV-2
M Meijers, D Ruchnewitz, J Eberhardt, M Łuksza, M Lässig
Cell 186 (23), 5151-5164. e13, 2023
72023
The system can't perform the operation now. Try again later.
Articles 1–20